Adaptive Biotechnologies ADPT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's operating lease ROU assets?
- Adaptive Biotechnologies (ADPT) reported operating lease ROU assets of $40.25M in Q1 2026.
- How has Adaptive Biotechnologies's operating lease ROU assets changed year-over-year?
- Adaptive Biotechnologies's operating lease ROU assets decreased by 8.5% year-over-year, from $44M to $40.25M.
- What is the long-term trend for Adaptive Biotechnologies's operating lease ROU assets?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating lease ROU assets has grown at a -16.4% compound annual growth rate (CAGR), from $99.35M to $40.62M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.